Abstract
In a randomly allocated, double-blind, placebo-controlled, crossover design, 50 patients with mild to moderate erectile dysfunction (ED) were treated for 1 month with placebo or a combination of L-arginine aspartate and Pycnogenol (Prelox). Patients reported sexual function from diaries. Testosterone levels and endothelial NO synthase (e-NOS) were monitored along with routine clinical chemistry. Intake of Pycnogenol for 1 month restored erectile function to normal. Intercourse frequency doubled. e-NOS in spermatozoa and testosterone levels in blood increased significantly. Cholesterol levels and blood pressure were lowered. No unwanted effects were reported. Prelox is a promising alternative to treat mild to moderate ED.
This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 8 print issues and online access
$259.00 per year
only $32.38 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
Similar content being viewed by others
References
Simonsen U, García Sacristán A, Prieto D . Penile arteries and erection. J Vasc Res 2002; 39: 283–303.
Chen J, Wollman Y, Chermichovsky T, Iaina A, Sofer M, Matzkin H . Effect of oral administration of high-dose nitric oxide donor L-arginine in men with organic erectile dysfunction: results of a double-blind, randomized, placebo-controlled study. BJU Int 1999; 83: 269–273.
Klotz T, Mathers MJ, Braun M, Bloch W, Engelmann U . Effectiveness of oral L-arginine in first-line treatment of erectile dysfunction in a controlled crossover study. Urol Int 1999; 63: 220–223.
Lebret T, Herve JM, Gorny P, Worcel M, Botto H . Efficacy and safety of a novel combination of L-arginine glutamate and yohimbine hydrochloride: a new oral therapy for erectile dysfunction. Eur Urol 2002; 41: 608–613.
Fitzpatrick DF, Bing B, Rohdewald P . Endothelium-dependent vascular effects of Pycnogenol. Cardiovasc Pharmacol 1998; 32: 509–515.
Durackova Z, Trebaticky B, Novotny V, Zitnanova A, Breza J . Lipid metabolism and erectile function improvement by Pycnogenol®, extract from the bark of Pinus pinaster in patients suffering from erectile dysfunction—apilot study. J Nutr Res 2003; 23: 1189–1198.
Rohdewald P . Pycnogenol, French maritime pine bark extract. In: Encyclopedia of Dietary Supplements. Marcel Dekker: New York, 2005, pp 545–553.
USP monograph: maritime pine bark extract. The United States Pharmacopoeia, United States Pharmacopoeial Convention, US Pharmacopoeia 28, 2024–2025.
Stanislavov R, Nikolova V . Treatment of erectile dysfunction with Pycnogenol® and L-arginine. J Sex Marital Ther 2003; 29: 207–213.
Lamm S, Schönlau F, Rohdewald P . Prelox for improvement of erectile function: a review. Eur Bull Drug Res 2003; 11: 29–37.
Rosen RC, Riley A, Wagner G, Osterloh IH, Kirkpatrick J, Mishra A . The international index of erectile function (IIEF): a multidimensional scale for assessment of erectile dysfunction. Urology 1997; 49: 822–830.
Stanislavov R, Nikolova V . Prelox® plus testosterone for achieve fertilization in previously infertile men. Eur Bull Drug Res 2005; 13: 7–13.
Raijfer J, Aronson W, Bush P, Dorey F, Ignarro L . Nitric oxide as a mediator of relaxation of the corpus cavernosum in response to noradrenergic noncholinergic neurotransmission. N Engl J Med 1992; 326: 90–94.
Cappelleri JC, Rosen RC, Smith MD, Mishra A, Osterloh IH . Diagnostic evaluation of the erectile function domain of the international index of erectile function. Urology 1999; 54: 346–351.
Garban H, Vernet D, Freedman A, Raijfer J, Conzales-Cadavid N . Effect of aging on nitric oxide-mediated penile erection in rats. Am J Physiol 1995; 268: H467–H475.
Carrier S, Nagaraju P, Morgan DM, Baba K, Nunes L, Lue TF . Age decreases nitric oxide synthase-containig nerve fibers in the rat penis. J Urol 1997; 157: 1088–1092.
Smith AR, Visioli F, Frei B, Hagen TM . Age-related changes in endothelial nitric oxide synthase phosphorylation and nitric oxide dependent vasodilation: evidence for a novel mechanism involving sphingomyelinase and ceramide-activated phosphatase 2A. Aging Cell 2006; 5: 391–400.
Wei ZH, Peng QL, Lau BHS . Pycnogenol® enhances endothelial cell antioxidant defenses. Redox Rep 1997; 3: 219–224.
Zini A, O'Bryan MK, Magid MS, Schlegel PN . Immunohistochemical localization of endothelial nitric oxide synthase in human testis, epididymis, and vas deferens suggests a possible role for nitric oxide in spermatogenesis, Sperm maturation, and programmed cell death. Biol Reprod 1996; 55: 935–941.
Soléru SG, Ennaji A, Cournot A, Spira A . LH pulsatile secretion and testosterone blood levels are influenced by sexual arousal in human males. Psychoneuroendocrinology 1993; 280: 205–218.
Soléru S, Gregoire MC, Gerard D, Decety J, Lafarge E, Cinotti L et al. Neuroanatomical correlates of visually evoked sexual arousal in human males. Arch Sex Behav 1999; 28: 1–21.
Heilhammer DH, Hubert W, Schürmeyer T . Changes in saliva testosterone after psychological stimulation in men. Psychoneuroendocrinology 1985; 10: 77–81.
Schweiger U, Deuschle M, Weber B, Korner A, Lammer CH, Schmider J et al. Testosterone gonadotropin and cortisol secretion in male patients with major depression. Psychosomat Med 1999; 61: 292–296.
Unden F, Ljunggren JG, Beck-Friis J, Kjellman BF, Wetterberg L . Hypothalamic-pituitary-gonadal axis in major depressive disorders. Acta Psychiatr Scand 1988; 78: 138–164.
Hosseini S, Lee J, Sepulveda RT, Fagan T, Rohdewald P, Watson RR . A randomized, double blind, placebo controlled, prospective, 16 week crossover study to determine the role of Pycnogenol® in modifying blood pressure in mildly hypertensive patients. Nutr Res 2001; 21: 67–76.
Liu X, Wei J, Tan F, Zhou S, Würthwein G, Rohdewald P . Pycnogenol®, French maritime pine bark extract, improves endothelial function of hypertensive patients. Life Sci 2004; 74: 855–862.
Devaraj S, Vega-López S, Kaul N, Schönlau F, Rohdewald P, Jialal I . Supplementation with a pine bark extract rich in polyphenols increases plasma antioxidant capacity and alters the plasma lipoprotein profile. Lipids 2002; 37: 931–934.
Koch R . Comparative study of Venostasin® and Pycnogenol® for treatment in chronic venous insufficiency. Phytother Res 2002; 16: 1–5.
Acknowledgements
We thank Dr J Gerß from the Institute of Medical Informatics and Biomathematics of the University Clinics Münster, Germany, for statistical evaluation of data. This study was funded by Horphag Research Ltd, UK.
Author information
Authors and Affiliations
Corresponding author
Additional information
Competing Interests
Dr Stanislavov received a grant from Horphag Research Ltd to perform this study. Dr Rohdewald is a consultant for Horphag Research Ltd and holds a patent for the method of increasing sexual wellness with a combination of proanthocyanidins and L-arginine.
Rights and permissions
About this article
Cite this article
Stanislavov, R., Nikolova, V. & Rohdewald, P. Improvement of erectile function with Prelox: a randomized, double-blind, placebo-controlled, crossover trial. Int J Impot Res 20, 173–180 (2008). https://doi.org/10.1038/sj.ijir.3901597
Received:
Revised:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1038/sj.ijir.3901597
Keywords
This article is cited by
-
Herbal Dietary Supplements for Erectile Dysfunction: A Systematic Review and Meta-Analysis
Drugs (2018)
-
Yohimbine relaxes the human corpus cavernosum through a non-adrenergic mechanism involving the activation of K+ATP-dependent channels
International Journal of Impotence Research (2009)